mhurhangee/ep-ind-claims huggingface dataset:
A sealant for sealing a puncture through tissue, comprising: an elongate rolled proximal section including a proximal end, a distal end wherein the distal end forms an end face, and a cross-section sized for delivery into a puncture through tissue, the proximal section formed from a rolled freeze-dried hydrogel that expands when exposed to physiological fluid within a puncture; and a distal section, the distal section formed from non-freeze-dried, non-crosslinked hydrogel precursors, the precursors remaining in an unreactive state until exposed to an aqueous physiological environment, whereupon the precursors undergo in-situ crosslinking with one another to provide an adhesive material for bonding adjacent tissue within the puncture, the distal section is a solid mass of the non-crosslinked precursors fused to and extending from the end face of the distal end of the rolled proximal section, wherein the solid mass comprises a uniform solid plug of the non-crosslinked precursors. an elongate rolled proximal section including a proximal end, a distal end wherein the distal end forms an end face, and a cross-section sized for delivery into a puncture through tissue, the proximal section formed from a rolled freeze-dried hydrogel that expands when exposed to physiological fluid within a puncture; and a distal section, the distal section formed from non-freeze-dried, non-crosslinked hydrogel precursors, the precursors remaining in an unreactive state until exposed to an aqueous physiological environment, whereupon the precursors undergo in-situ crosslinking with one another to provide an adhesive material for bonding adjacent tissue within the puncture, the distal section is a solid mass of the non-crosslinked precursors fused to and extending from the end face of the distal end of the rolled proximal section, wherein the solid mass comprises a uniform solid plug of the non-crosslinked precursors.
A polyester copolymer, having a number average molecular weight of equal to or more than 5000 grams/mole, determined through gel permeation chromatography at 25 °C using polystyrene standards and using a mixture of chloroform and 2-chlorophenol in a volumetric ratio of 6:4 (chloroform:2-chlorophenol) as eluent, and having a glass transition temperature of less than 160°C, measured using differential scanning calorimetry with a heating rate of 10 °C/ minute in a nitrogen atmosphere, which polymer contains: (a) in the range from equal to or more than 25 mole % to equal to or less than 49.9 mole %, based on the total amount of moles of monomer units within the polyester copolymer, of one or more bicyclic diol monomer units, wherein such one or more bicyclic diol monomer units is/are derived from one or more bicyclic diols chosen from the group consisting of isosorbide, isoidide, isomannide, 2,3:4,5-di-O-methylene-galactitol and 2,4:3,5-di-O-methylene-D-mannitol; (b) in the range from equal to or more than 45 mole % to equal to or less than 50 mole %, based on the total amount of moles of monomer units within the polyester copolymer, of an oxalate monomer unit; (c) in the range from equal to or more than 0.1 mole % to equal to or less than 25 mole %, based on the total amount of moles of monomer units within the polyester copolymer, of one or more linear C2-C12 diol monomer units, wherein such one or more linear C2-C12 diol monomer units is/are derived from one or more linear C2-C12 diols; and (d) optionally equal to or more than 0 mole % to equal to or less than 5 mole %, based on the total amount of moles of monomer units within the polyester copolymer, of one or more additional monomer units. (a) in the range from equal to or more than 25 mole % to equal to or less than 49.9 mole %, based on the total amount of moles of monomer units within the polyester copolymer, of one or more bicyclic diol monomer units, wherein such one or more bicyclic diol monomer units is/are derived from one or more bicyclic diols chosen from the group consisting of isosorbide, isoidide, isomannide, 2,3:4,5-di-O-methylene-galactitol and 2,4:3,5-di-O-methylene-D-mannitol; (b) in the range from equal to or more than 45 mole % to equal to or less than 50 mole %, based on the total amount of moles of monomer units within the polyester copolymer, of an oxalate monomer unit; (c) in the range from equal to or more than 0.1 mole % to equal to or less than 25 mole %, based on the total amount of moles of monomer units within the polyester copolymer, of one or more linear C2-C12 diol monomer units, wherein such one or more linear C2-C12 diol monomer units is/are derived from one or more linear C2-C12 diols; and (d) optionally equal to or more than 0 mole % to equal to or less than 5 mole %, based on the total amount of moles of monomer units within the polyester copolymer, of one or more additional monomer units.
A method for the recycling of used or discarded portable electrical batteries, such as saline, alkaline and small button batteries, which contain recoverable components such as iron, zinc, manganese, carbon, copper and dangerous heavy metals and organic/organo-metallic compounds such as mercury, nickel, lead, silver, pitch, chlorides or fluorides, characterised in that, as a feedstock, scrap and other feedstock components are introduced into a melting furnace for cast iron (1, 40, 44) containing manganese,scrap and other feedstock components, a quantity of used or discarded batteries in such a way that the quantity of manganese contained in these batteries corresponds to the quantity of manganese which must be introduced into the melting furnace in addition to the manganese contained in the scrap in order to obtain the required manganese content for the grade of cast iron in question, and in that a gas purification device (16, 23) is provided in the hot gas discharge path downstream of the melting furnace to capture and eliminate harmful elements such as mercury, chlorides or fluorides and heavy molecules such as furan and aromatic dioxins.
A laminated bag containing an active pharmaceutical ingredient characterized in that said laminated bag comprises an inner polyethylene layer completely embracing said active pharmaceutical ingredient, an aluminum layer completely embracing said inner polyethylene layer, and a nylon layer completely embracing said inner polyethylene layer, wherein said nylon layer is positioned between said polyethylene layer and said aluminum layer.
A method for dynamically configuring an uplink shared channel of a relay node in a communication system, wherein the relay node is connected to a base station over a first communication link that includes a first component carrier using the carrier frequency f2 and a second component carrier using the carrier frequency f1, and at least one user equipment is attached to the relay node over a second communication link using the carrier frequency f1, the method comprising the following step performed by the base station: dynamically instructing the relay node to deactivate/activate the uplink shared channel of the relay node for the second component carrier in pre-determined subframes, and characterized in that the step of instructing the relay node to deactivate/activate the uplink shared channel is based on traffic conditions in the first and second communication link. dynamically instructing the relay node to deactivate/activate the uplink shared channel of the relay node for the second component carrier in pre-determined subframes, and characterized in that the step of instructing the relay node to deactivate/activate the uplink shared channel is based on traffic conditions in the first and second communication link.
A compound of formula, wherein R 1 is wherein R 8 is cyano, C 1-6 alkyl, halogen, haloC 1-6 alkyl or nitro; R 2 is C 1-6 alkyl, C 3-7 cycloalkyl or haloC 1-6 alkyl; R 3 is wherein R 4 and R 5 are independently selected from H and C 1-6 alkyl; R 6 is H, halogen, C 1-6 alkyl or heterocyclyl; R 7 is H or C 1-6 alkyl; m is 0, 1, 2 or 3; n is 1, 2 or 3; or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof. R 1 is wherein R 8 is cyano, C 1-6 alkyl, halogen, haloC 1-6 alkyl or nitro; R 2 is C 1-6 alkyl, C 3-7 cycloalkyl or haloC 1-6 alkyl; R 3 is wherein R 4 and R 5 are independently selected from H and C 1-6 alkyl; R 6 is H, halogen, C 1-6 alkyl or heterocyclyl; R 7 is H or C 1-6 alkyl; m is 0, 1, 2 or 3; n is 1, 2 or 3; R 4 and R 5 are independently selected from H and C 1-6 alkyl; R 6 is H, halogen, C 1-6 alkyl or heterocyclyl; R 7 is H or C 1-6 alkyl; m is 0, 1, 2 or 3; n is 1, 2 or 3; or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof.
A preparation method for an acrylate compound, the acrylate compound has a structure represented by formula the method comprises: subjecting a compound with a structure represented by formula or a mixture of a compound with a structure represented by formula and a compound with a structure represented by formula to have a contact reaction with a catalyst which is selected from at least one of dimethyl sulfate and diethyl sulfate in the absence of acid anhydride, and removing the methanol produced in the contact reaction process by reduced pressure distillation, wherein, R is selected from one of C1-C5 alkoxy, C6-C20 phenoxyl with a substituent group, C4-C20 heteroaryloxy with a substituent group, C4-C20 heteroaryloxymethyl with a substituent group, C5-C20 phenoxymethyl with a substituent group, and C2-C20 alkyl with a substituent group, and chloromethyl.
NC program that is run on a laser machine, a punching machine, or a laser punching combination machine for machining a plurality of different workpiece parts from a flat starting material by means of different tools, wherein the NC program comprises an NC production program with the NC program steps (31a-31e) required to produce the workpiece parts, characterised in that in addition to the NC production program, the NC program comprises for each of the producible different workpiece parts an extractable data set in the form of prefabricated individual part NC codes, in which there are stored the types of tools and tool steps including the associated machining parameters, necessary for the post-production of such an individual workpiece part.
A bi-specific antibody comprising a first antigen-binding site that specifically binds to LOXL2 and a second antigen-binding site that specifically binds to CCL2.
A process of purifying a compound II wherein X is a leaving group, comprising crystallising compound II using a solvent system comprising a polar and a non-polar solvent, wherein the polar solvent comprises formic acid, acetic acid, propionic acid, butyric acid or methanol.
Apparatus for binary frequency shift keying modulation, comprising: a phase locked loop PLL configured to provide a high frequency clock; a digital rate converter coupled to the PLL and configured to convert the high frequency clock into first and second clock signals that each have a lower frequency than the high frequency clock, the first clock signal having only a first predetermined number of consecutive pulses within a period of time that contains only a second predetermined number of consecutive pulses of the high frequency clock, the second clock signal having only the first predetermined number of consecutive pulses within a period of time that contains only a third predetermined number of consecutive pulses of the high frequency clock, wherein the second and third predetermined numbers differ from one another and are both greater than the first predetermined number, and wherein the digital rate converter is configured to select between the first and second clock signals based on binary data values selected for transmission; a digital phase generator coupled to the digital rate converter and configured to generate a plurality of digital phase signals corresponding to a selected one of the first and second clock signals; and a driver coupled to the digital phase generator and configured to weight digital phase signals from the digital phase generator to synthesize an output waveform having binary data values modulated thereon. a phase locked loop PLL configured to provide a high frequency clock; a digital rate converter coupled to the PLL and configured to convert the high frequency clock into first and second clock signals that each have a lower frequency than the high frequency clock, the first clock signal having only a first predetermined number of consecutive pulses within a period of time that contains only a second predetermined number of consecutive pulses of the high frequency clock, the second clock signal having only the first predetermined number of consecutive pulses within a period of time that contains only a third predetermined number of consecutive pulses of the high frequency clock, wherein the second and third predetermined numbers differ from one another and are both greater than the first predetermined number, and wherein the digital rate converter is configured to select between the first and second clock signals based on binary data values selected for transmission; a digital phase generator coupled to the digital rate converter and configured to generate a plurality of digital phase signals corresponding to a selected one of the first and second clock signals; and a driver coupled to the digital phase generator and configured to weight digital phase signals from the digital phase generator to synthesize an output waveform having binary data values modulated thereon.
A method by a terminal for handling messages from network nodes of a wireless communications system, the method comprising: receiving a message from a network node; determining that the message contains a reconfigurationWithSync field and that security is not activated; and responsive to the determining, preventing triggering of a handover operation; wherein preventing triggering of the handover operation comprises transitioning the terminal to an RRC_IDLE state. receiving a message from a network node; determining that the message contains a reconfigurationWithSync field and that security is not activated; and responsive to the determining, preventing triggering of a handover operation; wherein preventing triggering of the handover operation comprises transitioning the terminal to an RRC_IDLE state.
A blood treatment device for treating a patient's blood comprising an apparatus configured to control the blood treatment device in accordance with or based on one or more values of a first parameter calculated or approximated or estimated by a method carried out by the apparatus, the apparatus being configured to carry out said method, the method comprising the steps: - interpolating or extrapolating of at least one later value of the first parameter, taking into account - at least one earlier value of the first parameter, - at least one earlier and at least one later value of a second parameter, and - a mathematical relation between the first and the second parameter, and - controlling the blood treatment device in accordance with or based on the at least one calculated or approximated or estimated value; wherein the first parameter is only one parameter selected from a group of parameters, the group consisting of the overhydration and the relative overhydration (relOH), and wherein the second parameter is the preweight (before treatment). - interpolating or extrapolating of at least one later value of the first parameter, taking into account - at least one earlier value of the first parameter, - at least one earlier and at least one later value of a second parameter, and - a mathematical relation between the first and the second parameter, and - at least one earlier value of the first parameter, - at least one earlier and at least one later value of a second parameter, and - a mathematical relation between the first and the second parameter, and - controlling the blood treatment device in accordance with or based on the at least one calculated or approximated or estimated value;
A method for operating a vehicle, wherein - a control unit of a vehicle calculates a trajectory (53, 53') of the vehicle depending on operational data of a further vehicle, the operational data being transmitted from the further vehicle to the vehicle via wireless connections (20, 21) being established to a radio access network by respective wireless communication units (52, 62) of the vehicle and the further vehicle; and - calculating the trajectory (53, 53') comprises taking into account a data handling delay of the received operational data, wherein an edge data center being connected to the radio access network calculates the data handling delay and transmits the calculated data handling delay to the vehicle. - a control unit of a vehicle calculates a trajectory (53, 53') of the vehicle depending on operational data of a further vehicle, the operational data being transmitted from the further vehicle to the vehicle via wireless connections (20, 21) being established to a radio access network by respective wireless communication units (52, 62) of the vehicle and the further vehicle; and - calculating the trajectory (53, 53') comprises taking into account a data handling delay of the received operational data, wherein an edge data center being connected to the radio access network calculates the data handling delay and transmits the calculated data handling delay to the vehicle.
A kit product comprising: a bag which contains an infusion solution or pure water; and a drug-enclosing portion in which a drug is enclosed and which comprises a sealing portion connecting the drug-enclosing portion with the bag via the sealing portion, wherein the sealing portion is adapted such that a drug preparation is enabled by opening the sealing portion to bring the bag into communication with the drug-enclosing portion, thereby charging the drug into the bag, wherein the kit product contains further drug-enclosing portions which comprise a sealing portion, characterized in that the same drug is enclosed in the further drug enclosing portions, such that the kit product enables dose adjustment of the drug, as at least some of the drug-enclosing portions is configured to be able to isolate a residue of the drug, which remains in the drug-enclosing portion without being used in the drug preparation, from the bag, wherein the drug is dose-adjustable by adjusting the number of the sealing portions to be opened, wherein each of the drug-enclosing portions displays the amount of the drug enclosed therein on its surface by printing or stamping. a bag which contains an infusion solution or pure water; and a drug-enclosing portion in which a drug is enclosed and which comprises a sealing portion connecting the drug-enclosing portion with the bag via the sealing portion, wherein the sealing portion is adapted such that a drug preparation is enabled by opening the sealing portion to bring the bag into communication with the drug-enclosing portion, thereby charging the drug into the bag,
A terminal comprising a processor configured for: - requesting a call server to set up a call from this first terminal, used by a first user, and destined to a first number of a second user; - requesting the call server to register, in a directory of the call server, a second number of the second user, and a logical relationship between the number of the first user and the registered second number of the second user, so that this call server memorizes that it is authorized to forward a call to the second number of the second user only if this call is originating from the number of the first user; characterized in that said processor is further configured for: - automatically detecting that a new entry, corresponding to the second number of the second user, has been registered in the phone book of this terminal, and then automatically sending a request to the call server for checking whether the name of the second user is registered in a directory of the call server; - and if the name of the second user is registered in said directory, sending a request, from this terminal to said call server, requesting the call server to register the number of the first user and a logical relationship between the number of the first user and the registered second number of the second user, for the purpose of forwarding. - requesting a call server to set up a call from this first terminal, used by a first user, and destined to a first number of a second user; - requesting the call server to register, in a directory of the call server, a second number of the second user, and a logical relationship between the number of the first user and the registered second number of the second user, so that this call server memorizes that it is authorized to forward a call to the second number of the second user only if this call is originating from the number of the first user; - automatically detecting that a new entry, corresponding to the second number of the second user, has been registered in the phone book of this terminal, and then automatically sending a request to the call server for checking whether the name of the second user is registered in a directory of the call server; - and if the name of the second user is registered in said directory, sending a request, from this terminal to said call server, requesting the call server to register the number of the first user and a logical relationship between the number of the first user and the registered second number of the second user, for the purpose of forwarding.